Lakeshore Financial Planning’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$346K Buy
1,374
+1
+0.1% +$215 0.11% 61
2026
Q1
$299K Buy
1,373
+2
+0.1% +$444 0.11% 60
2025
Q4
$313K Buy
1,371
+34
+3% +$7.75K 0.11% 59
2025
Q3
$310K Buy
1,337
+3
+0.2% +$611 0.12% 53
2025
Q2
$248K Buy
1,334
+6
+0.5% +$1.11K 0.1% 66
2025
Q1
$278K Buy
1,328
+1
+0.1% +$194 0.12% 54
2024
Q4
$236K Buy
1,327
+1
+0.1% +$184 0.1% 63
2024
Q3
$262K Buy
1,326
+1
+0.1% +$187 0.12% 57
2024
Q2
$227K Buy
1,325
+1
+0.1% +$166 0.11% 59
2024
Q1
$241K Buy
1,324
+4
+0.3% +$689 0.12% 54
2023
Q4
$205K Sell
1,320
-135
-9% -$19.7K 0.11% 60
2023
Q3
$217K Buy
+1,455
New +$214K 0.12% 56

Other funds holding ABBV

Lakeshore Financial Planning's ABBV Position: Q2 2026 in Review

Lakeshore Financial Planning increased its AbbVie (ABBV) stake by 0.07% in Q2 2026, buying an estimated $215 and bringing the position to 1,374 shares worth $346K. The position accounts for 0.11% of the portfolio, ranked #61.

Lakeshore Financial Planning first reported a position in ABBV in Q3 2023 and has held it in 12 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Lakeshore Financial Planning held 1,374 shares of AbbVie worth $346K as of Q2 2026.
  • Lakeshore Financial Planning bought 1 AbbVie share in Q2 2026, an estimated $215.
  • AbbVie made up 0.11% of Lakeshore Financial Planning's portfolio in Q2 2026, its #61 holding.
  • Lakeshore Financial Planning first reported a position in AbbVie in Q3 2023 and has held it in 12 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Lakeshore Financial Planning's 13F filing for Q2 2026, filed 13 Jul 2026.